FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1438-1443 May 20, 1993 Number 20 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background and Methods Irregular disfiguring skin hyperpigmentation due to inflammation may develop in black persons. We investigated the treatment of this hyperpigmentation with topical tretinoin (0.1 percent retinoic acid cream). Fifty-four subjects completed a 40-week randomized, double-blind, vehicle-controlled study. Twenty-four subjects applied tretinoin daily to the face, arms, or both areas, and 30 subjects applied vehicle cream. At base line and after 40 weeks of treatment, each subject's postinflammatory hyperpigmented lesions and normal skin were assessed by clinical and colorimetric evaluations and by analysis of biopsy specimens.

Results The facial postinflammatory hyperpigmented lesions of the tretinoin-treated subjects were significantly lighter after the 40 weeks of therapy than those of the vehicle-treated subjects (P<0.001); overall improvement was first noted after 4 weeks of tretinoin treatment. At the end of treatment, colorimetry demonstrated a 40 percent lightening of the lesions toward normal skin color in the tretinoin-treated lesions, as compared with an 18 percent lightening in vehicle-treated lesions (P = 0.05). The epidermal melanin content in the lesions decreased by 23 percent with tretinoin and by 3 percent with vehicle (P = 0.24). Normal skin was minimally lightened by tretinoin as compared with vehicle, according to both clinical evaluation (0.1 vs. -0.1 unit change on an 8-point scale; P = 0.055) and colorimetry (P<0.001). Retinoid dermatitis developed in 12 of the 24 tretinoin-treated subjects who completed the study (50 percent) and in 1 tretinoin-treated subject who withdrew from the study, but diminished as the study progressed.

Conclusions Topical application of tretinoin significantly lightens postinflammatory hyperpigmentation; to a clinically minimal but statistically significant degree, it also lightens normal skin in black persons.

Source Information

From the Dermatopharmacology Unit, Department of Dermatology, University of Michigan Medical Center, Ann Arbor. During part of this study Dr. Ellis and Dr. Voorhees served as consultants to the Johnson & Johnson Corporation (of which the Ortho Pharmaceutical Corporation is a subsidiary).

Address reprint requests to Dr. Voorhees at the Department of Dermatology, University of Michigan Medical Center, 1910 Taubman Ctr., 1500 E. Medical Ctr. Dr., Ann Arbor, MI 48109-0314.

Full Text of this Article

Related Letters:

Visceral Leishmaniasis in Desert Storm Veterans
Boyer M. H., Magill A. J., Grogl M., Gasser R. A., Oster C. N.
Extract | Full Text  
N Engl J Med 1993; 329:1503-1504, Nov 11, 1993. Correspondence

This article has been cited by other articles:

• Slominski, A., Tobin, D. J., Shibahara, S., Wortsman, J. (2004). Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation. Physiol. Rev. 84: 1155-1228 [Abstract] [Full Text]  
• Xiao, J.-H., Durand, Béa., Chambon, P., Voorhees, J. J. (1995). Endogenous Retinoic Acid Receptor (RAR)-Retinoid X Receptor (RXR) Heterodimers Are the Major Functional Forms Regulating Retinoid-responsive Elements in Adult Human Keratinocytes. J. Biol. Chem. 270: 3001-3011 [Abstract] [Full Text]  
• Romero, C, Aberdam, E, Larnier, C, Ortonne, J. (1994). Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression. J. Cell Sci. 107: 1095-1103 [Abstract]  
• (1993). Tretinoin Clears Postinflammatory Hyperpigmentation in Black Persons. Journal Watch Dermatology 1993: 2-2 [Full Text]  
• Fairley, J. A. (1993). Tretinoin (Retinoic Acid) Revisited. NEJM 328: 1486-1487 [Full Text]